Infectious Complications in Critically Ill Children and Young Adults Receiving Continuous Kidney Replacement Therapy

被引：0

作者：

Menon, Shina ^{[1
]}

Iyer, Sai Prasad N. ^{[2
]}

Humes, H. David ^{[3
]}

Goldstein, Stuart ^{[4
]}

Damian, Mihaela ^{[1
]}

Cappoli, Andrea ^{[8
]}

Joseph, Catherine ^{[9
]}

Soranno, Danielle Elise ^{[5
]}

Starr, Michelle C. ^{[5
]}

Tolwani, Ashita J. ^{[6
]}

Chung, Kevin K. ^{[2
]}

Mottes, Theresa Ann ^{[7
]}

Zang Huaiyu ^{[4
]}

Ollberding, Nicholas J. ^{[4
]}

Gist, Katja M. ^{[4
]}

机构：

[1] Stanford Univ, Sch Med, Stanford, CA USA

[2] Seastar Med, Denver, CO USA

[3] Univ Michigan Hlth Syst, Ann Arbor, MI USA

[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA

[5] Indiana Univ Sch Med, Indianapolis, IN USA

[6] Univ Alabama Birmingham, Med Sch Birmingham, Birmingham, AL USA

[7] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA

[8] Osped Pediat Bambino Gesu, Rome, Italy

[9] Texas Childrens Hosp, Houston, TX USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期

关键词：

D O I：

10.1681/ASN.20240ynq81c1

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

TH-PO079

引用

页数：2

共 50 条

[41] Body temperature and infection in critically ill patients on continuous kidney replacement therapy
Douglas W. Challener
Xiaolan Gao
Shahrzad Tehranian
Kianoush B. Kashani
John C. O’Horo
BMC Nephrology, 24
[42] Body temperature and infection in critically ill patients on continuous kidney replacement therapy
Challener, Douglas W.
Gao, Xiaolan
Tehranian, Shahrzad
Kashani, Kianoush B.
O'Horo, John C.
BMC NEPHROLOGY, 2023, 24 (01)
[43] Optimal levofloxacin dosing regimens in critically ill patients with acute kidney injury receiving continuous renal replacement therapy
Rungkitwattanakul, Dhakrit
Chaijamorn, Weerachai
Charoensareerat, Taniya
Charntrakarn, Pratarn
Khamkampud, Orapan
Rattanaponpasert, Nakumporn
Srisawat, Nattachai
Pattharachayakul, Sutthiporn
JOURNAL OF CRITICAL CARE, 2021, 63 : 154 - 160
[44] Meropenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy
Chaijamorn, Weerachai
Rungkitwattanakul, Dhakrit
Pattharachayakul, Sutthiporn
Singhan, Wanchana
Charoensareerat, Taniya
Srisawat, Nattachai
JOURNAL OF CRITICAL CARE, 2020, 60 : 285 - 289
[45] Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
Jang, Soo Min
Infante, Sergio
Pour, Amir Abdi
PHARMACY, 2020, 8 (01)
[46] Impact of Downtime on Clinical Outcomes in Critically Ill Patients with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy
Shin, Jungho
Song, Hyun Chul
Hwang, Jin Ho
Kim, Su Hyun
ASAIO JOURNAL, 2022, 68 (05) : 744 - 752
[47] LEVETIRACETAM DOSING RECOMMENDATIONS FOR CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS RENAL REPLACEMENT THERAPY
Chaijamorn, Weerachai
Charoensareerat, Taniya
Sathienluckana, Thanompong
Phunpon, Sathian
Pattharachayakul, Sutthiporn
Rungkitwattanakul, Dhakrit
Srisawat, Nattachai
NEPHROLOGY, 2020, 25 : 43 - 43
[48] Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy
Vaara, S.
Pettila, V.
Kaukonen, K. -M.
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2012, 56 (02) : 147 - 157
[49] Cefepime Pharmacokinetics in Critically Ill Pediatric Patients Receiving Continuous Renal Replacement Therapy
Stitt, Gideon
Morris, Jennifer
Schmees, Lindsay
Angelo, Joseph
Arikan, Ayse Akcan
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
[50] Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy
Trotman, RL
Williamson, JC
Shoemaker, DM
Salzer, WL
CLINICAL INFECTIOUS DISEASES, 2005, 41 (08) : 1159 - 1166

← 1 2 3 4 5 →